Fort Washington Investment Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
BTW
CIM
RP
CFM
PFSRSONJ
JIC
IHL
Fort Washington Investment Advisors's CRL Position: Q2 2026 in Review
Fort Washington Investment Advisors held its Charles River Laboratories (CRL) position steady in Q2 2026 at 1,300 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #381.
Fort Washington Investment Advisors first reported a position in CRL in Q1 2019 and has held it in 22 quarters since. The position peaked at $408K in Q3 2020. 105 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Fort Washington Investment Advisors held 1,300 shares of Charles River Laboratories worth $295K as of Q2 2026.
- Fort Washington Investment Advisors left its Charles River Laboratories share count unchanged in Q2 2026.
- Charles River Laboratories made up ﹤0.01% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #381 holding.
- Fort Washington Investment Advisors first reported a position in Charles River Laboratories in Q1 2019 and has held it in 22 quarters since.
- Fort Washington Investment Advisors's Charles River Laboratories position peaked at $408K in Q3 2020.
- 105 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.